Haemonetics Corporation
HAE
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technologā¦ read more
Healthcare
Medical Instruments & Supplies
34 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$59.92
Price+0.72%
$0.43
1Y
Price
Market Cap
$2.805b
Mid
Price/Earnings 3y Avg5y Avg
16.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+28.2%
EBITDA Margin+13.2%
Net Profit Margin+25.7%
Free Cash Flow Margin+28.2%
EBITDA Margin+13.2%
Net Profit Margin+25.7%
Free Cash Flow MarginRevenue
$1.318b
-3.1%
1y CAGR+4.3%
3y CAGR+7.6%
5y CAGREarnings
$175.436m
+4.6%
1y CAGR+16.4%
3y CAGR+53.8%
5y CAGREPS
$3.63
+9.7%
1y CAGR+18.8%
3y CAGR+55.8%
5y CAGRBook Value
$911.451m
$2.491b
Assets$1.579b
Liabilities$1.225b
DebtDebt to Assets
49.2%
3.3x
Debt to EBITDAFree Cash Flow
$308.075m
+116.3%
1y CAGR+36.9%
3y CAGR+56.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company